MLAB:NGS-Mesa Laboratories Inc. (USD)

EQUITY | Scientific & Technical Instruments | Nasdaq Global Select

Last Closing

USD 100.62

Change

0.00 (0.00)%

Market Cap

USD 0.50B

Volume

0.04M

Analyst Target

USD 271.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Mesa Laboratories Inc designs, manufactures and markets quality control instruments and disposable products and also manufactures and markets biological indicators and distributes chemical indicators.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-01 )

Largest Industry Peers for Scientific & Technical Instruments

Symbol Name Price(Change) Market Cap
TRMB Trimble Inc

-0.43 (-0.60%)

USD 15.41B
MKSI MKS Instruments Inc

+0.30 (+0.37%)

USD 5.40B
ITRI Itron Inc

+0.86 (+0.74%)

USD 4.95B
CGNX Cognex Corporation

-0.29 (-0.97%)

USD 4.62B
NOVT Novanta Inc

-1.90 (-1.53%)

USD 4.42B
FARO FARO Technologies Inc

+0.04 (+0.09%)

USD 0.81B
ITRN Ituran Location and Control Lt..

+1.10 (+2.88%)

USD 0.73B
MVIS Microvision Inc

+0.01 (+0.91%)

USD 0.30B
SOTK Sono-Tek Corp

-0.13 (-3.38%)

USD 0.06B
MIND Mind Technology Inc

-0.08 (-1.32%)

USD 0.05B

ETFs Containing MLAB

N/A

Market Performance

  Market Performance vs. Industry/Classification (Scientific & Technical Instruments) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.70% 16% F 28% F
Dividend Return 0.12% 25% F 3% F
Total Return -23.58% 16% F 28% F
Trailing 12 Months  
Capital Gain 5.14% 68% D+ 63% D
Dividend Return 0.50% 50% F 11% F
Total Return 5.64% 68% D+ 61% D-
Trailing 5 Years  
Capital Gain -59.61% 38% F 23% F
Dividend Return 1.22% 25% F 3% F
Total Return -58.39% 38% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain -12.91% 15% F 5% F
Dividend Return -12.58% 15% F 5% F
Total Return 0.33% 29% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 27.59% 54% F 33% F
Risk Adjusted Return -45.60% 8% B- 6% D-
Market Capitalization 0.50B 59% D- 64% D

Key Financial Ratios

  Ratio vs. Industry/Classification (Scientific & Technical Instruments) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 44.80 8% 1%
Price/Book Ratio 3.44 35% 32%
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio 16.61 29% 23%
Management Effectiveness  
Return on Equity -1.29% 44% 56%
Return on Invested Capital 7.36% 78% 72%
Return on Assets 2.50% 61% 74%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.